Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
TCRX
Stock Latest News
Market News
Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street
22d ago
CRVO
TCRX
Premium
The Fly
TScan Therapeutics price target raised to $5 from $4 at Wedbush
22d ago
TCRX
Premium
Ratings
TScan Therapeutics: Strengthening Heme-Focused TCR-T Platform and Regulatory Momentum Support Buy Rating and $7 Target
23d ago
TCRX
Premium
The Fly
TScan Therapeutics reports Q4 EPS (18c), consensus (28c)
23d ago
TCRX
Premium
The Fly
TScan Therapeutics sees cash runway into 2H27
23d ago
TCRX
Premium
Ratings
TScan Therapeutics: Clinical Momentum in TSC-101 and Pipeline Expansion Underpin Buy Rating Despite Cash Constraints
24d ago
TCRX
Premium
The Fly
TScan Therapeutics completes enrollment into Cohort C of ALLOHA study
29d ago
TCRX
Premium
Company Announcements
TScan Therapeutics Outlines Pivotal 2026 Outlook in Presentation
2M ago
8K
TCRX
Premium
Ratings
Hold Rating for TScan Therapeutics Amid Promising Data and Awaited Future Developments
4M ago
TCRX
Premium
Ratings
TScan Therapeutics: Overcoming Manufacturing Setbacks with Strategic Adjustments and Promising Potential in Myeloid Malignancies
4M ago
TCRX
Premium
Ratings
Promising Potential of TScan Therapeutics’ TSC-101: Analyst Recommends Buy Rating
4M ago
TCRX
Premium
The Fly
TScan Therapeutics announces updated data from ALLOHA Phase 1 trial
4M ago
TCRX
Premium
Company Announcements
TScan Therapeutics Approves Key Employee Retention Program
4M ago
8K
TCRX
Premium
The Fly
TScan Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
4M ago
TCRX
Premium
Company Announcements
TScan Therapeutics Reports Increased Revenue Amid Rising Losses
4M ago
TCRX
Premium
Ratings
TScan Therapeutics: Strategic Focus and Financial Stability Drive Buy Rating
4M ago
TCRX
Premium
Ratings
Promising Phase I Results and Strategic Adjustments Support Buy Rating for TScan Therapeutics
4M ago
TCRX
Premium
The Fly
TScan Therapeutics reports Q3 EPS (28c), consensus (33c)
5M ago
TCRX
Premium
The Fly
TScan Therapeutics downgraded to Neutral from Buy at BTIG
5M ago
TCRX
Premium
The Fly
TScan Therapeutics downgraded to Neutral from Buy at BTIG
5M ago
TCRX
Premium
The Fly
TScan Therapeutics price target lowered to $6 from $9 at Needham
5M ago
TCRX
Premium
Ratings
TScan Therapeutics’ TSC-101 Gains Buy Rating Amid Promising Trial Results and Strategic Focus on Heme Program
5M ago
TCRX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
